Small, but significant reduction seen in prostate cancer deaths, but no reduction seen in all-cause mortality. Small, but significant reduction seen in prostate cancer deaths, but no reduction seen in all-cause mortality.
A single invitation for prostate-specific antigen screening is associated with reduced prostate cancer deaths, although the absolute reduction is small.